Takehiro Nakao

Safety and efficacy of mucosal immunotherapy using human papillomavirus (HPV) type 16 E7-expressing Lactobacillus-based vaccine for the treatment of high-grade squamous intraepithelial lesion (HSIL): the study protocol of a randomized placebo-controlled clinical trial (MILACLE study)

Yuji Ikeda, Yukari Uemura, Mikiko Asai‐Sato et al. · Japanese Journal of Clinical Oncology · 2019 · 22 citations

Medicine, Immunology, Oncology +17

Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer

Hiromichi Nakajima, Kenichi Harano, Tokiko Nakai et al. · The Breast · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of Ado-Trastuzumab Emtansine and Fam-Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring <i>HER2</i> Amplification and the L755S Mutation

Toru Mukohara, Ako Hosono, Sachiyo Mimaki et al. · The Oncologist · 2021 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Expression of Angiotensin II Types 1 and 2 Receptors in Endometriotic Lesions

Takehiro Nakao, Fumihisa Chishima, Masahiko Sugitani et al. · Gynecologic and Obstetric Investigation · 2016 · 13 citations

Medicine, Gynecology, Molecular Biology +12

Reconstructed uterine length is critical for the prevention of cervical stenosis following abdominal trachelectomy in cervical cancer patients

Takahiro Nakajima, Akiko Kasuga, Aki Hara‐Yamashita et al. · Journal of obstetrics and gynaecology research · 2020 · 13 citations

Medicine, Oncology, Surgery +14